Per Svenningsson - Publications

Pharmacology, KI 
Receptors, basal ganglia

226 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Sitzia G, Mantas I, Zhang X, Svenningsson P, Chergui K. NMDA receptors are altered in the substantia nigra pars reticulata and their blockade ameliorates motor deficits in experimental parkinsonism. Neuropharmacology. 108136. PMID 32474027 DOI: 10.1016/j.neuropharm.2020.108136  0.6
2020 Zhang X, Mantas I, Fridjonsdottir E, Andrén PE, Chergui K, Svenningsson P. Deficits in Motor Performance, Neurotransmitters and Synaptic Plasticity in Elderly and Experimental Parkinsonian Mice Lacking GPR37. Frontiers in Aging Neuroscience. 12: 84. PMID 32292338 DOI: 10.3389/fnagi.2020.00084  0.6
2020 Schintu N, Zhang X, Stroth N, Mathé AA, Andrén PE, Svenningsson P. Non-dopaminergic Alterations in Depression-Like FSL Rats in Experimental Parkinsonism and L-DOPA Responses. Frontiers in Pharmacology. 11: 304. PMID 32265703 DOI: 10.3389/fphar.2020.00304  0.52
2020 Hulme H, Fridjonsdottir E, Gunnarsdottir H, Vallianatou T, Zhang X, Wadensten H, Shariatgorji R, Nilsson A, Bezard E, Svenningsson P, Andrén PE. Simultaneous mass spectrometry imaging of multiple neuropeptides in the brain and alterations induced by experimental parkinsonism and L-DOPA therapy. Neurobiology of Disease. 104738. PMID 31927144 DOI: 10.1016/j.nbd.2020.104738  0.52
2019 Mantas I, Yang Y, Mannoury-la-Cour C, Millan MJ, Zhang X, Svenningsson P. Genetic deletion of GPR88 enhances the locomotor response to L-DOPA in experimental parkinsonism while counteracting the induction of dyskinesia. Neuropharmacology. 107829. PMID 31666199 DOI: 10.1016/j.neuropharm.2019.107829  0.52
2019 Shariatgorji M, Nilsson A, Fridjonsdottir E, Vallianatou T, Källback P, Katan L, Sävmarker J, Mantas I, Zhang X, Bezard E, Svenningsson P, Odell LR, Andrén PE. Comprehensive mapping of neurotransmitter networks by MALDI-MS imaging. Nature Methods. PMID 31548706 DOI: 10.1038/s41592-019-0551-3  0.52
2019 Puschmann A, Jiménez-Ferrer I, Lundblad-Andersson E, Mårtensson E, Hansson O, Odin P, Widner H, Brolin K, Mzezewa R, Kristensen J, Soller M, Rödström EY, Ross OA, Toft M, Breedveld GJ, ... ... Svenningsson P, et al. Low prevalence of known pathogenic mutations in dominant PD genes: A Swedish multicenter study. Parkinsonism & Related Disorders. PMID 31422003 DOI: 10.1016/j.parkreldis.2019.07.032  0.44
2019 Paslawski W, Zareba-Paslawska J, Zhang X, Hölzl K, Wadensten H, Shariatgorji M, Janelidze S, Hansson O, Forsgren L, Andrén PE, Svenningsson P. α-synuclein-lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson's disease patients. Proceedings of the National Academy of Sciences of the United States of America. PMID 31270237 DOI: 10.1073/pnas.1821409116  0.52
2019 Vallianatou T, Shariatgorji M, Nilsson A, Fridjonsdottir E, Källback P, Schintu N, Svenningsson P, Andrén PE. Molecular imaging identifies age-related attenuation of acetylcholine in retrosplenial cortex in response to acetylcholinesterase inhibition. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31009936 DOI: 10.1038/s41386-019-0397-5  0.52
2019 Green H, Tsitsi P, Markaki I, Aarsland D, Svenningsson P. Novel Treatment Opportunities Against Cognitive Impairment in Parkinson's Disease with an Emphasis on Diabetes-Related Pathways. Cns Drugs. PMID 30687888 DOI: 10.1007/s40263-018-0601-x  0.44
2018 Zhang X, Mantas I, Alvarsson A, Yoshitake T, Shariatgorji M, Pereira M, Nilsson A, Kehr J, Andrén PE, Millan MJ, Chergui K, Svenningsson P. Striatal Tyrosine Hydroxylase Is Stimulated via TAAR1 by 3-Iodothyronamine, But Not by Tyramine or β-Phenylethylamine. Frontiers in Pharmacology. 9: 166. PMID 29545750 DOI: 10.3389/fphar.2018.00166  0.64
2018 Vallianatou T, Strittmatter N, Nilsson A, Shariatgorji M, Hamm G, Pereira M, Källback P, Svenningsson P, Karlgren M, Goodwin RJA, Andrén PE. A mass spectrometry imaging approach for investigating how drug-drug interactions influence drug blood-brain barrier permeability. Neuroimage. PMID 29329980 DOI: 10.1016/j.neuroimage.2018.01.013  0.32
2017 Andréasson M, Brodin L, Laffita-Mesa JM, Svenningsson P. Correlations Between Methionine Cycle Metabolism, COMT Genotype, and Polyneuropathy in L-Dopa Treated Parkinson's Disease: A Preliminary Cross-Sectional Study. Journal of Parkinson's Disease. PMID 28759974 DOI: 10.3233/JPD-171127  0.44
2017 Bereczki E, Bogstedt A, Höglund K, Tsitsi P, Brodin L, Ballard C, Svenningsson P, Aarsland D. Synaptic proteins in CSF relate to Parkinson's disease stage markers. Npj Parkinson's Disease. 3: 7. PMID 28649607 DOI: 10.1038/s41531-017-0008-2  0.44
2017 Ran C, Wirdefeldt K, Brodin L, Ramezani M, Westerlund M, Xiang F, Anvret A, Willows T, Sydow O, Johansson A, Galter D, Svenningsson P, Belin AC. Genetic Variations and mRNA Expression of NRF2 in Parkinson's Disease. Parkinson's Disease. 2017: 4020198. PMID 28540099 DOI: 10.1155/2017/4020198  0.44
2017 Rame M, Caudal D, Schenker E, Svenningsson P, Spedding M, Jay TM, Godsil BP. Clozapine counteracts a ketamine-induced depression of hippocampal-prefrontal neuroplasticity and alters signaling pathway phosphorylation. Plos One. 12: e0177036. PMID 28472198 DOI: 10.1371/journal.pone.0177036  0.36
2017 Monnot C, Zhang X, Nikkhou-Aski S, Damberg P, Svenningsson P. Asymmetric dopaminergic degeneration and levodopa alter functional corticostriatal connectivity bilaterally in experimental parkinsonism. Experimental Neurology. PMID 28223037 DOI: 10.1016/j.expneurol.2017.02.014  0.52
2017 Green H, Zhang X, Tiklova K, Volakakis N, Brodin L, Berg L, Greengard P, Perlmann T, Svenningsson P. Alterations of p11 in brain tissue and peripheral blood leukocytes in Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America. PMID 28137881 DOI: 10.1073/pnas.1621218114  1
2016 Milosevic A, Liebmann T, Knudsen M, Schintu N, Svenningsson P, Greengard P. Cell- and region-specific expression of depression-related protein p11 (S100a10) in the brain. The Journal of Comparative Neurology. PMID 27616678 DOI: 10.1002/cne.24113  1
2016 Svenningsson P, Wirdefeldt K, Yin L, Fang F, Markaki I, Efendic S, Ludvigsson JF. Reduced incidence of Parkinson's disease after dipeptidyl peptidase-4 inhibitors-A nationwide case-control study. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27431803 DOI: 10.1002/mds.26734  1
2016 Bigio B, Mathé AA, Sousa VC, Zelli D, Svenningsson P, McEwen BS, Nasca C. Epigenetics and energetics in ventral hippocampus mediate rapid antidepressant action: Implications for treatment resistance. Proceedings of the National Academy of Sciences of the United States of America. PMID 27354525 DOI: 10.1073/pnas.1603111113  0.44
2016 Ran C, Brodin L, Forsgren L, Westerlund M, Ramezani M, Gellhaar S, Xiang F, Fardell C, Nissbrandt H, Söderkvist P, Puschmann A, Ygland E, Olson L, Willows T, Johansson A, ... ... Svenningsson P, et al. Strong association between glucocerebrosidase mutations and Parkinson's disease in Sweden. Neurobiology of Aging. PMID 27255555 DOI: 10.1016/j.neurobiolaging.2016.04.022  0.44
2016 Shariatgorji M, Strittmatter N, Nilsson A, Källback P, Alvarsson A, Zhang X, Vallianatou T, Svenningsson P, Goodwin RJ, Andren PE. Simultaneous imaging of multiple neurotransmitters and neuroactive substances in the brain by desorption electrospray ionization mass spectrometry. Neuroimage. PMID 27155126 DOI: 10.1016/j.neuroimage.2016.05.004  0.64
2016 Marongiu R, Arango-Lievano M, Francardo V, Morgenstern P, Zhang X, Cenci MA, Svenningsson P, Greengard P, Kaplitt MG. Gene therapy blockade of dorsal striatal p11 improves motor function and dyskinesia in parkinsonian mice. Proceedings of the National Academy of Sciences of the United States of America. PMID 26787858 DOI: 10.1073/pnas.1524387113  1
2016 Schintu N, Zhang X, Alvarsson A, Marongiu R, Kaplitt MG, Greengard P, Svenningsson P. p11 modulates L-DOPA therapeutic effects and dyskinesia via distinct cell types in experimental Parkinsonism. Proceedings of the National Academy of Sciences of the United States of America. PMID 26787846 DOI: 10.1073/pnas.1524303113  1
2015 Yang J, Hertz E, Zhang X, Leinartaité L, Lundius EG, Li J, Svenningsson P. Overexpression of α-synuclein simultaneously increases glutamate NMDA receptor phosphorylation and reduces glucocerebrosidase activity. Neuroscience Letters. PMID 26610904 DOI: 10.1016/j.neulet.2015.11.023  1
2015 Paucar M, Lindestad PÅ, Walker RH, Svenningsson P. Teaching Video NeuroImages: Feeding dystonia in chorea-acanthocytosis. Neurology. 85: e143-4. PMID 26553947 DOI: 10.1212/WNL.0000000000002108  1
2015 Stroth N, Svenningsson P. S100B interacts with the serotonin 5-HT7 receptor to regulate a depressive-like behavior. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26499172 DOI: 10.1016/j.euroneuro.2015.10.003  1
2015 Alvarsson A, Zhang X, Stan TL, Schintu N, Kadkhodaei B, Millan MJ, Perlmann T, Svenningsson P. Modulation by Trace Amine-Associated Receptor 1 of Experimental Parkinsonism, l-DOPA Responsivity, and Glutamatergic Neurotransmission. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 14057-69. PMID 26468205 DOI: 10.1523/JNEUROSCI.1312-15.2015  1
2015 Pereira M, Martynhak BJ, Andreatini R, Svenningsson P. 5-HT6 receptor agonism facilitates emotional learning. Frontiers in Pharmacology. 6: 200. PMID 26441657 DOI: 10.3389/fphar.2015.00200  1
2015 Caudal D, Alvarsson A, Björklund A, Svenningsson P. Depressive-like phenotype induced by AAV-mediated overexpression of human α-synuclein in midbrain dopaminergic neurons. Experimental Neurology. 273: 243-252. PMID 26363495 DOI: 10.1016/j.expneurol.2015.09.002  1
2015 Alvarsson A, Caudal D, Björklund A, Svenningsson P. Emotional memory impairments induced by AAV-mediated overexpression of human α-synuclein in dopaminergic neurons of the ventral tegmental area. Behavioural Brain Research. 296: 129-133. PMID 26341317 DOI: 10.1016/j.bbr.2015.08.034  1
2015 Stan TL, Sousa VC, Zhang X, Ono M, Svenningsson P. Lurasidone and fluoxetine reduce novelty-induced hypophagia and NMDA receptor subunit and PSD-95 expression in mouse brain. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26256011 DOI: 10.1016/j.euroneuro.2015.07.007  1
2015 Jucaite A, Svenningsson P, Rinne JO, Cselényi Z, Varnäs K, Johnström P, Amini N, Kirjavainen A, Helin S, Minkwitz M, Kugler AR, Posener JA, Budd S, Halldin C, Varrone A, et al. Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease. Brain : a Journal of Neurology. 138: 2687-700. PMID 26137956 DOI: 10.1093/brain/awv184  1
2015 Legati A, Giovannini D, Nicolas G, López-Sánchez U, Quintáns B, Oliveira JR, Sears RL, Ramos EM, Spiteri E, Sobrido MJ, Carracedo Á, Castro-Fernández C, Cubizolle S, Fogel BL, Goizet C, ... ... Svenningsson P, et al. Mutations in XPR1 cause primary familial brain calcification associated with altered phosphate export. Nature Genetics. 47: 579-81. PMID 25938945 DOI: 10.1038/ng.3289  1
2015 Laguna A, Schintu N, Nobre A, Alvarsson A, Volakakis N, Jacobsen JK, Gómez-Galán M, Sopova E, Joodmardi E, Yoshitake T, Deng Q, Kehr J, Ericson J, Svenningsson P, Shupliakov O, et al. Dopaminergic control of autophagic-lysosomal function implicates Lmx1b in Parkinson's disease. Nature Neuroscience. 18: 826-35. PMID 25915474 DOI: 10.1038/nn.4004  1
2015 Varrone A, Svenningsson P, Marklund P, Fatouros-Bergman H, Forsberg A, Halldin C, Nilsson LG, Farde L. 5-HT1B receptor imaging and cognition: a positron emission tomography study in control subjects and Parkinson's disease patients. Synapse (New York, N.Y.). 69: 365-74. PMID 25914348 DOI: 10.1002/syn.21823  1
2015 Herth MM, Andersen VL, Hansen HD, Stroth N, Volk B, Lehel S, Dyssegaard A, Ettrup A, Svenningsson P, Knudsen GM, Kristensen JL. Evaluation of 3-Ethyl-3-(phenylpiperazinylbutyl)oxindoles as PET Ligands for the Serotonin 5-HT₇ Receptor: Synthesis, Pharmacology, Radiolabeling, and in Vivo Brain Imaging in Pigs. Journal of Medicinal Chemistry. 58: 3631-6. PMID 25825999 DOI: 10.1021/acs.jmedchem.5b00095  1
2015 Shariatgorji M, Nilsson A, Källback P, Karlsson O, Zhang X, Svenningsson P, Andren PE. Pyrylium Salts as Reactive Matrices for MALDI-MS Imaging of Biologically Active Primary Amines. Journal of the American Society For Mass Spectrometry. 26: 934-9. PMID 25821050 DOI: 10.1007/s13361-015-1119-9  1
2015 Kiselycznyk C, Jury NJ, Halladay LR, Nakazawa K, Mishina M, Sprengel R, Grant SG, Svenningsson P, Holmes A. NMDA receptor subunits and associated signaling molecules mediating antidepressant-related effects of NMDA-GluN2B antagonism. Behavioural Brain Research. 287: 89-95. PMID 25800971 DOI: 10.1016/j.bbr.2015.03.023  1
2015 Fazio P, Svenningsson P, Forsberg A, Jönsson EG, Amini N, Nakao R, Nag S, Halldin C, Farde L, Varrone A. Quantitative Analysis of ¹⁸F-(E)-N-(3-Iodoprop-2-Enyl)-2β-Carbofluoroethoxy-3β-(4'-Methyl-Phenyl) Nortropane Binding to the Dopamine Transporter in Parkinson Disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 714-20. PMID 25791993 DOI: 10.2967/jnumed.114.152421  1
2015 Paul G, Zachrisson O, Varrone A, Almqvist P, Jerling M, Lind G, Rehncrona S, Linderoth B, Bjartmarz H, Shafer LL, Coffey R, Svensson M, Mercer KJ, Forsberg A, Halldin C, ... Svenningsson P, et al. Safety and tolerability of intracerebroventricular PDGF-BB in Parkinson's disease patients. The Journal of Clinical Investigation. 125: 1339-46. PMID 25689258 DOI: 10.1172/JCI79635  1
2015 Lleó A, Cavedo E, Parnetti L, Vanderstichele H, Herukka SK, Andreasen N, Ghidoni R, Lewczuk P, Jeromin A, Winblad B, Tsolaki M, Mroczko B, Visser PJ, Santana I, Svenningsson P, et al. Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases. Nature Reviews. Neurology. 11: 41-55. PMID 25511894 DOI: 10.1038/nrneurol.2014.232  1
2015 Martinez-Martin P, Reddy P, Katzenschlager R, Antonini A, Todorova A, Odin P, Henriksen T, Martin A, Calandrella D, Rizos A, Bryndum N, Glad A, Dafsari HS, Timmermann L, Ebersbach G, ... ... Svenningsson P, et al. EuroInf: a multicenter comparative observational study of apomorphine and levodopa infusion in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 510-6. PMID 25382161 DOI: 10.1002/mds.26067  1
2015 Machaczka M, Kämpe Björkvall C, Wieremiejczyk J, Paucar Arce M, Myhr-Eriksson K, Klimkowska M, Hägglund H, Svenningsson P. Impact of imiglucerase supply shortage on clinical and laboratory parameters in norrbottnian patients with Gaucher disease type 3. Archivum Immunologiae Et Therapiae Experimentalis. 63: 65-71. PMID 25205209 DOI: 10.1007/s00005-014-0308-8  1
2015 Kraepelien M, Svenningsson P, Lindefors N, Kaldo V. Internet-based cognitive behavioral therapy for depression and anxiety in parkinson's disease - a pilot study Internet Interventions. 2: 1-6. DOI: 10.1016/j.invent.2014.11.006  1
2015 Stroth N, Niso M, Colabufo NA, Perrone R, Svenningsson P, Lacivita E, Leopoldo M. Arylpiperazine agonists of the serotonin 5-HT1A receptor preferentially activate cAMP signaling versus recruitment of β-arrestin-2 Bioorganic and Medicinal Chemistry. DOI: 10.1016/j.bmc.2015.05.042  1
2014 Shariatgorji M, Nilsson A, Goodwin RJ, Källback P, Schintu N, Zhang X, Crossman AR, Bezard E, Svenningsson P, Andren PE. Direct targeted quantitative molecular imaging of neurotransmitters in brain tissue sections. Neuron. 84: 697-707. PMID 25453841 DOI: 10.1016/j.neuron.2014.10.011  1
2014 Svenningsson P. Reductions of p11 and 5-HT1B receptor availability in limbic brain regions in cocaine dependence. Biological Psychiatry. 76: 763-4. PMID 25442058 DOI: 10.1016/j.biopsych.2014.08.011  1
2014 Tiger M, Svenningsson P, Nord M, Jabre S, Halldin C, Lundberg J. No correlation between serotonin and its metabolite 5-HIAA in the cerebrospinal fluid and [(11) C]AZ10419369 binding measured with PET in healthy volunteers. Synapse (New York, N.Y.). 68: 480-3. PMID 24988901 DOI: 10.1002/syn.21761  1
2014 Stan TL, Alvarsson A, Branzell N, Sousa VC, Svenningsson P. NMDA receptor antagonists ketamine and Ro25-6981 inhibit evoked release of glutamate in vivo in the subiculum. Translational Psychiatry. 4: e395. PMID 24893066 DOI: 10.1038/tp.2014.39  1
2014 Mavrikaki M, Schintu N, Nomikos GG, Panagis G, Svenningsson P. Ropinirole regulates emotionality and neuronal activity markers in the limbic forebrain. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 1981-93. PMID 24852388 DOI: 10.1017/S1461145714000728  1
2014 Wen L, Jin Y, Li L, Sun S, Cheng S, Zhang S, Zhang Y, Svenningsson P. Exercise prevents raphe nucleus mitochondrial overactivity in a rat depression model. Physiology & Behavior. 132: 57-65. PMID 24813829 DOI: 10.1016/j.physbeh.2014.04.050  1
2014 Pereira JB, Svenningsson P, Weintraub D, Brønnick K, Lebedev A, Westman E, Aarsland D. Initial cognitive decline is associated with cortical thinning in early Parkinson disease. Neurology. 82: 2017-25. PMID 24808018 DOI: 10.1212/WNL.0000000000000483  1
2014 Salvesen L, Tanassi JT, Bech S, PÃ¥lhagen S, Svenningsson P, Heegaard NH, Winge K. The influence of preanalytical conditions on the DJ-1 concentration in human cerebrospinal fluid. Biomarkers in Medicine. 8: 387-94. PMID 24712430 DOI: 10.2217/bmm.13.125  1
2014 Svenningsson P, Berg L, Matthews D, Ionescu DF, Richards EM, Niciu MJ, Malinger A, Toups M, Manji H, Trivedi MH, Zarate CA, Greengard P. Preliminary evidence that early reduction in p11 levels in natural killer cells and monocytes predicts the likelihood of antidepressant response to chronic citalopram. Molecular Psychiatry. 19: 962-4. PMID 24614495 DOI: 10.1038/mp.2014.13  1
2014 Shrestha SS, Nelson EE, Liow JS, Gladding R, Lyoo CH, Noble PL, Morse C, Henter ID, Kruger J, Zhang B, Suomi SJ, Svenningsson P, Pike VW, Winslow JT, Leibenluft E, et al. Fluoxetine administered to juvenile monkeys: effects on the serotonin transporter and behavior. The American Journal of Psychiatry. 171: 323-31. PMID 24480874 DOI: 10.1176/appi.ajp.2013.13020183  1
2014 Shrestha SS, Liow JS, Lu S, Jenko K, Gladding RL, Svenningsson P, Morse CL, Zoghbi SS, Pike VW, Innis RB. (11)C-CUMI-101, a PET radioligand, behaves as a serotonin 1A receptor antagonist and also binds to α(1) adrenoceptors in brain. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 141-6. PMID 24385311 DOI: 10.2967/jnumed.113.125831  1
2014 Lundius EG, Vukojevic V, Hertz E, Stroth N, Cederlund A, Hiraiwa M, Terenius L, Svenningsson P. GPR37 protein trafficking to the plasma membrane regulated by prosaposin and GM1 gangliosides promotes cell viability. The Journal of Biological Chemistry. 289: 4660-73. PMID 24371137 DOI: 10.1074/jbc.M113.510883  1
2014 Saeed A, Floris F, Andersson U, Pikuleva I, Lövgren-Sandblom A, Bjerke M, Paucar M, Wallin A, Svenningsson P, Björkhem I. 7α-hydroxy-3-oxo-4-cholestenoic acid in cerebrospinal fluid reflects the integrity of the blood-brain barrier. Journal of Lipid Research. 55: 313-8. PMID 24319290 DOI: 10.1194/jlr.P044982  1
2014 Shrestha SS, Pine DS, Luckenbaugh DA, Varnäs K, Henter ID, Innis RB, Mathé AA, Svenningsson P. Antidepressant effects on serotonin 1A/1B receptors in the rat brain using a gene x environment model. Neuroscience Letters. 559: 163-8. PMID 24287374 DOI: 10.1016/j.neulet.2013.11.034  1
2014 Mavrikaki M, Schintu N, Kastellakis A, Nomikos GG, Svenningsson P, Panagis G. Effects of lithium and aripiprazole on brain stimulation reward and neuroplasticity markers in the limbic forebrain. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 630-8. PMID 24275700 DOI: 10.1016/j.euroneuro.2013.10.014  1
2014 Varrone A, Svenningsson P, Forsberg A, Varnäs K, Tiger M, Nakao R, Halldin C, Nilsson LG, Farde L. Positron emission tomography imaging of 5-hydroxytryptamine1B receptors in Parkinson's disease. Neurobiology of Aging. 35: 867-75. PMID 24126162 DOI: 10.1016/j.neurobiolaging.2013.08.025  1
2014 Shariatgorji M, Svenningsson P, Andrén PE. Mass spectrometry imaging, an emerging technology in neuropsychopharmacology. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 34-49. PMID 23966069 DOI: 10.1038/npp.2013.215  1
2013 Paucar M, Xiang F, Moore R, Walker R, Winnberg E, Svenningsson P. Genotype-phenotype analysis in inherited prion disease with eight octapeptide repeat insertional mutation. Prion. 7: 501-10. PMID 24275071 DOI: 10.4161/pri.27260  1
2013 Björkhem I, Lövgren-Sandblom A, Leoni V, Meaney S, Brodin L, Salveson L, Winge K, PÃ¥lhagen S, Svenningsson P. Oxysterols and Parkinson's disease: evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease. Neuroscience Letters. 555: 102-5. PMID 24035896 DOI: 10.1016/j.neulet.2013.09.003  1
2013 Svenningsson P, Kim Y, Warner-Schmidt J, Oh YS, Greengard P. p11 and its role in depression and therapeutic responses to antidepressants. Nature Reviews. Neuroscience. 14: 673-80. PMID 24002251 DOI: 10.1038/nrn3564  1
2013 Laffita-Mesa JM, Rodríguez Pupo JM, Moreno Sera R, Vázquez Mojena Y, Kourí V, Laguna-Salvia L, Martínez-Godales M, Valdevila Figueira JA, Bauer PO, Rodríguez-Labrada R, González Zaldívar Y, Paucar M, Svenningsson P, Velázquez Pérez L. De novo mutations in ataxin-2 gene and ALS risk. Plos One. 8: e70560. PMID 23936447 DOI: 10.1371/journal.pone.0070560  1
2013 Keller A, Westenberger A, Sobrido MJ, García-Murias M, Domingo A, Sears RL, Lemos RR, Ordoñez-Ugalde A, Nicolas G, da Cunha JE, Rushing EJ, Hugelshofer M, Wurnig MC, Kaech A, Reimann R, ... ... Svenningsson P, et al. Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice. Nature Genetics. 45: 1077-82. PMID 23913003 DOI: 10.1038/ng.2723  1
2013 Kiselycznyk C, Zhang X, Huganir RL, Holmes A, Svenningsson P. Reduced phosphorylation of GluA1 subunits relates to anxiety-like behaviours in mice. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 919-24. PMID 23360771 DOI: 10.1017/S1461145712001174  1
2013 Kadkhodaei B, Alvarsson A, Schintu N, Ramsköld D, Volakakis N, Joodmardi E, Yoshitake T, Kehr J, Decressac M, Björklund A, Sandberg R, Svenningsson P, Perlmann T. Transcription factor Nurr1 maintains fiber integrity and nuclear-encoded mitochondrial gene expression in dopamine neurons. Proceedings of the National Academy of Sciences of the United States of America. 110: 2360-5. PMID 23341612 DOI: 10.1073/pnas.1221077110  1
2013 Hsu SC, Sears RL, Lemos RR, Quintáns B, Huang A, Spiteri E, Nevarez L, Mamah C, Zatz M, Pierce KD, Fullerton JM, Adair JC, Berner JE, Bower M, Brodaty H, ... ... Svenningsson P, et al. Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification. Neurogenetics. 14: 11-22. PMID 23334463 DOI: 10.1007/s10048-012-0349-2  1
2013 Lundius EG, Stroth N, Vukojević V, Terenius L, Svenningsson P. Functional GPR37 trafficking protects against toxicity induced by 6-OHDA, MPP+ or rotenone in a catecholaminergic cell line. Journal of Neurochemistry. 124: 410-7. PMID 23121049 DOI: 10.1111/jnc.12081  1
2013 Eriksson TM, Alvarsson A, Stan TL, Zhang X, Hascup KN, Hascup ER, Kehr J, Gerhardt GA, Warner-Schmidt J, Arango-Lievano M, Kaplitt MG, Ogren SO, Greengard P, Svenningsson P. Bidirectional regulation of emotional memory by 5-HT1B receptors involves hippocampal p11. Molecular Psychiatry. 18: 1096-105. PMID 23032875 DOI: 10.1038/mp.2012.130  1
2013 Aarsland D, Svenningsson P. Using biomarkers to disentangle different causes of Parkinsonism. Journal of Neurology, Neurosurgery, and Psychiatry. 84: 119. PMID 22949480 DOI: 10.1136/jnnp-2012-303025  1
2013 Shrestha S, Liow JS, Gladding R, Pike VW, Noble PL, Winslow JT, Suomi SJ, Svenningsson P, Nelson EE, Pine DS, Innis RB. PET Imaging of Serotonin Transmission in Monkeys: Effects of Maternal Separation and Long-Term Fluoxetine Treatment during Adolescence Catecholamine Research in the 21st Century: Abstracts and Graphical Abstracts, 10th International Catecholamine Symposium, 2012. 157-158. DOI: 10.1016/B978-0-12-800044-1.00139-2  1
2012 Skorpil M, Söderlund V, Sundin A, Svenningsson P. MRI diffusion in Parkinson's disease: using the technique's inherent directional information to study the olfactory bulb and substantia nigra. Journal of Parkinson's Disease. 2: 171-80. PMID 23939442 DOI: 10.3233/JPD-2012-12091  1
2012 Schintu N, Zhang X, Svenningsson P. Studies of depression-related states in animal models of Parkinsonism. Journal of Parkinson's Disease. 2: 87-106. PMID 23939436 DOI: 10.3233/JPD-2012-12076  1
2012 Machaczka M, Arce MP, Rucinska M, Yoshitake T, Kehr J, Jurczak W, Skotnicki AB, Månsson JE, Tylki-Szymanska A, Svenningsson P. A twelve-year follow-up study on a case of early-onset parkinsonism preceding clinical manifestation of Gaucher disease. Jimd Reports. 3: 53-7. PMID 23430873 DOI: 10.1007/8904_2011_48  0.36
2012 Liebmann T, Kruusmägi M, Sourial-Bassillious N, Bondar A, Svenningsson P, Flajolet M, Greengard P, Scott L, Brismar H, Aperia A. A noncanonical postsynaptic transport route for a GPCR belonging to the serotonin receptor family. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 17998-8008. PMID 23238716 DOI: 10.1523/JNEUROSCI.1804-12.2012  1
2012 Egeland M, Zhang X, Millan MJ, Mocaer E, Svenningsson P. Pharmacological or genetic blockade of the dopamine D3 receptor increases cell proliferation in the hippocampus of adult mice. Journal of Neurochemistry. 123: 811-23. PMID 22957735 DOI: 10.1111/jnc.12011  1
2012 Shariatgorji M, Nilsson A, Goodwin RJ, Svenningsson P, Schintu N, Banka Z, Kladni L, Hasko T, Szabo A, Andren PE. Deuterated matrix-assisted laser desorption ionization matrix uncovers masked mass spectrometry imaging signals of small molecules. Analytical Chemistry. 84: 7152-7. PMID 22860714 DOI: 10.1021/ac301498m  1
2012 Svenningsson P, Westman E, Ballard C, Aarsland D. Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment. The Lancet. Neurology. 11: 697-707. PMID 22814541 DOI: 10.1016/S1474-4422(12)70152-7  1
2012 Aarsland D, Ballard C, Rongve A, Broadstock M, Svenningsson P. Clinical trials of dementia with Lewy bodies and Parkinson's disease dementia. Current Neurology and Neuroscience Reports. 12: 492-501. PMID 22806065 DOI: 10.1007/s11910-012-0290-7  1
2012 Eriksson TM, Holst S, Stan TL, Hager T, Sjögren B, Ogren SÖ, Svenningsson P, Stiedl O. 5-HT1A and 5-HT7 receptor crosstalk in the regulation of emotional memory: implications for effects of selective serotonin reuptake inhibitors. Neuropharmacology. 63: 1150-60. PMID 22801295 DOI: 10.1016/j.neuropharm.2012.06.061  1
2012 Lacivita E, Patarnello D, Stroth N, Caroli A, Niso M, Contino M, De Giorgio P, Di Pilato P, Colabufo NA, Berardi F, Perrone R, Svenningsson P, Hedlund PB, Leopoldo M. Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin(7) (5-HT(7)) receptor with agonist or antagonist action in vitro or ex vivo. Journal of Medicinal Chemistry. 55: 6375-80. PMID 22738316 DOI: 10.1021/jm3003679  1
2012 Shariatgorji M, Källback P, Gustavsson L, Schintu N, Svenningsson P, Goodwin RJ, Andren PE. Controlled-pH tissue cleanup protocol for signal enhancement of small molecule drugs analyzed by MALDI-MS imaging. Analytical Chemistry. 84: 4603-7. PMID 22507246 DOI: 10.1021/ac203322q  1
2012 Aarsland D, PÃ¥hlhagen S, Ballard CG, Ehrt U, Svenningsson P. Depression in Parkinson disease--epidemiology, mechanisms and management. Nature Reviews. Neurology. 8: 35-47. PMID 22198405 DOI: 10.1038/nrneurol.2011.189  1
2012 Shrestha S, Hirvonen J, Hines CS, Henter ID, Svenningsson P, Pike VW, Innis RB. Serotonin-1A receptors in major depression quantified using PET: controversies, confounds, and recommendations. Neuroimage. 59: 3243-51. PMID 22155042 DOI: 10.1016/j.neuroimage.2011.11.029  1
2012 Nilsson A, Stroth N, Zhang X, Qi H, Fälth M, Sköld K, Hoyer D, Andrén PE, Svenningsson P. Neuropeptidomics of mouse hypothalamus after imipramine treatment reveal somatostatin as a potential mediator of antidepressant effects. Neuropharmacology. 62: 347-57. PMID 21856315 DOI: 10.1016/j.neuropharm.2011.08.004  1
2012 Melas PA, Rogdaki M, Lennartsson A, Björk K, Qi H, Witasp A, Werme M, Wegener G, Mathé AA, Svenningsson P, Lavebratt C. Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 669-79. PMID 21682946 DOI: 10.1017/S1461145711000940  1
2012 Eriksson TM, Delagrange P, Spedding M, Popoli M, Mathé AA, Ögren SO, Svenningsson P. Emotional memory impairments in a genetic rat model of depression: involvement of 5-HT/MEK/Arc signaling in restoration. Molecular Psychiatry. 17: 173-84. PMID 21242991 DOI: 10.1038/mp.2010.131  1
2012 Stroth N, Svenningsson P. Ligand-specific differential regulation of 5-hydroxytryptamine receptors: Functional selectivity in serotonergic signaling Wiley Interdisciplinary Reviews: Membrane Transport and Signaling. 1: 453-466. DOI: 10.1002/wmts.39  1
2011 Di Cara B, Maggio R, Aloisi G, Rivet JM, Lundius EG, Yoshitake T, Svenningsson P, Brocco M, Gobert A, De Groote L, Cistarelli L, Veiga S, De Montrion C, Rodriguez M, Galizzi JP, et al. Genetic deletion of trace amine 1 receptors reveals their role in auto-inhibiting the actions of ecstasy (MDMA). The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 16928-40. PMID 22114263 DOI: 10.1523/JNEUROSCI.2502-11.2011  1
2011 Szegedi V, Juhász G, Zhang X, Barkóczi B, Qi H, Madeira A, Kapus G, Svenningsson P, Spedding M, Penke B. Tianeptine potentiates AMPA receptors by activating CaMKII and PKA via the p38, p42/44 MAPK and JNK pathways. Neurochemistry International. 59: 1109-22. PMID 22056552 DOI: 10.1016/j.neuint.2011.10.008  1
2011 Madeira A, Vikeved E, Nilsson A, Sjögren B, Andrén PE, Svenningsson P. Identification of protein-protein interactions by surface plasmon resonance followed by mass spectrometry. Current Protocols in Protein Science / Editorial Board, John E. Coligan ... [Et Al.]. Unit19.21. PMID 21842469 DOI: 10.1002/0471140864.ps1921s65  1
2011 Surette AP, Madureira PA, Phipps KD, Miller VA, Svenningsson P, Waisman DM. Regulation of fibrinolysis by S100A10 in vivo. Blood. 118: 3172-81. PMID 21768297 DOI: 10.1182/blood-2011-05-353482  1
2011 Kiselycznyk C, Svenningsson P, Delpire E, Holmes A. Genetic, pharmacological and lesion analyses reveal a selective role for corticohippocampal GLUN2B in a novel repeated swim stress paradigm. Neuroscience. 193: 259-68. PMID 21704131 DOI: 10.1016/j.neuroscience.2011.06.015  1
2011 Madeira A, Yang J, Zhang X, Vikeved E, Nilsson A, Andrén PE, Svenningsson P. Caveolin-1 interacts with alpha-synuclein and mediates toxic actions of cellular alpha-synuclein overexpression. Neurochemistry International. 59: 280-9. PMID 21693152 DOI: 10.1016/j.neuint.2011.05.017  1
2011 Zhang X, Egeland M, Svenningsson P. Antidepressant-like properties of sarizotan in experimental Parkinsonism. Psychopharmacology. 218: 621-34. PMID 21647579 DOI: 10.1007/s00213-011-2356-7  1
2011 Zhang X, Andren PE, Glennon RA, Svenningsson P. Distribution, level, pharmacology, regulation, and signaling of 5-HT6 receptors in rats and marmosets with special reference to an experimental model of parkinsonism. The Journal of Comparative Neurology. 519: 1816-27. PMID 21452237 DOI: 10.1002/cne.22605  1
2011 Egeland M, Warner-Schmidt J, Greengard P, Svenningsson P. Co-expression of serotonin 5-HT(1B) and 5-HT(4) receptors in p11 containing cells in cerebral cortex, hippocampus, caudate-putamen and cerebellum. Neuropharmacology. 61: 442-50. PMID 21300076 DOI: 10.1016/j.neuropharm.2011.01.046  1
2011 Björk K, Svenningsson P. Modulation of monoamine receptors by adaptor proteins and lipid rafts: role in some effects of centrally acting drugs and therapeutic agents. Annual Review of Pharmacology and Toxicology. 51: 211-42. PMID 20887195 DOI: 10.1146/annurev-pharmtox-010510-100520  1
2011 Skorpil M, Rolheiser T, Robertson H, Sundin A, Svenningsson P. Diffusion tensor fiber tractography of the olfactory tract. Magnetic Resonance Imaging. 29: 289-92. PMID 20850236 DOI: 10.1016/j.mri.2010.07.004  1
2011 Lauth M, Rohnalter V, Bergström A, Kooshesh M, Svenningsson P, Toftgård R. Antipsychotic drugs regulate hedgehog signaling by modulation of 7-dehydrocholesterol reductase levels (Molecular Pharmacology (2010) 78, (486-496)) Molecular Pharmacology. 79: 793. DOI: 10.1124/mol.79.4.793  1
2010 Alexander B, Warner-Schmidt J, Eriksson T, Tamminga C, Arango-Lievano M, Arango-Llievano M, Ghose S, Vernov M, Stavarache M, Stavarche M, Musatov S, Flajolet M, Svenningsson P, Greengard P, Kaplitt MG. Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens. Science Translational Medicine. 2: 54ra76. PMID 20962330 DOI: 10.1126/scitranslmed.3001079  1
2010 Warner-Schmidt JL, Chen EY, Zhang X, Marshall JJ, Morozov A, Svenningsson P, Greengard P. A role for p11 in the antidepressant action of brain-derived neurotrophic factor. Biological Psychiatry. 68: 528-35. PMID 20591415 DOI: 10.1016/j.biopsych.2010.04.029  1
2010 Lauth M, Rohnalter V, Bergström A, Kooshesh M, Svenningsson P, ToftgÃ¥rd R. Antipsychotic drugs regulate hedgehog signaling by modulation of 7-dehydrocholesterol reductase levels. Molecular Pharmacology. 78: 486-96. PMID 20558592 DOI: 10.1124/mol.110.066431  1
2010 O'Connell PA, Surette AP, Liwski RS, Svenningsson P, Waisman DM. S100A10 regulates plasminogen-dependent macrophage invasion. Blood. 116: 1136-46. PMID 20424186 DOI: 10.1182/blood-2010-01-264754  1
2010 Egeland M, Warner-Schmidt J, Greengard P, Svenningsson P. Neurogenic effects of fluoxetine are attenuated in p11 (S100A10) knockout mice. Biological Psychiatry. 67: 1048-56. PMID 20227680 DOI: 10.1016/j.biopsych.2010.01.024  1
2010 Björk K, Sjögren B, Svenningsson P. Regulation of serotonin receptor function in the nervous system by lipid rafts and adaptor proteins. Experimental Cell Research. 316: 1351-6. PMID 20211176 DOI: 10.1016/j.yexcr.2010.02.034  1
2010 PÃ¥lhagen S, Qi H, MÃ¥rtensson B, WÃ¥linder J, Granérus AK, Svenningsson P. Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson's disease and major depression. Journal of Neurology. 257: 524-32. PMID 19844754 DOI: 10.1007/s00415-009-5353-6  1
2010 McEwen BS, Chattarji S, Diamond DM, Jay TM, Reagan LP, Svenningsson P, Fuchs E. The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation. Molecular Psychiatry. 15: 237-49. PMID 19704408 DOI: 10.1038/mp.2009.80  1
2010 Alexander B, Warner-Schmidt J, Eriksson T, Tamminga C, Arango-Lievano M, Ghose S, Vernov M, Stavarache M, Musatov S, Flajolet M, Svenningsson P, Greengard P, Kaplitt MG. Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens (Science Translational Medicine (2010) 2, (62er4)) Science Translational Medicine. 2. DOI: 10.1126/scitranslmed.3001996  1
2010 Alexander B, Warner-Schmidt J, Eriksson T, Tamminga C, Arango-Llievano M, Ghose S, Vernov M, Stavarche M, Musatov S, Flajolet M, Svenningsson P, Greengard P, Kaplitt MG. Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens (Science Translational Medicine (2010) 2, (55er3)) Science Translational Medicine. 2. DOI: 10.1126/scitranslmed.3001841  1
2009 Madeira A, Ohman E, Nilsson A, Sjögren B, Andrén PE, Svenningsson P. Coupling surface plasmon resonance to mass spectrometry to discover novel protein-protein interactions. Nature Protocols. 4: 1023-37. PMID 19536270 DOI: 10.1038/nprot.2009.84  1
2009 Warner-Schmidt JL, Flajolet M, Maller A, Chen EY, Qi H, Svenningsson P, Greengard P. Role of p11 in cellular and behavioral effects of 5-HT4 receptor stimulation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 1937-46. PMID 19211900 DOI: 10.1523/JNEUROSCI.5343-08.2009  1
2009 Svensson M, Boren M, Sköld K, Fälth M, Sjögren B, Andersson M, Svenningsson P, Andren PE. Heat stabilization of the tissue proteome: a new technology for improved proteomics. Journal of Proteome Research. 8: 974-81. PMID 19159280 DOI: 10.1021/pr8006446  1
2009 Nilsson A, Fälth M, Zhang X, Kultima K, Sköld K, Svenningsson P, Andrén PE. Striatal alterations of secretogranin-1, somatostatin, prodynorphin, and cholecystokinin peptides in an experimental mouse model of Parkinson disease. Molecular & Cellular Proteomics : McP. 8: 1094-104. PMID 19131325 DOI: 10.1074/mcp.M800454-MCP200  1
2009 Kindlundh-Högberg AM, Zhang X, Svenningsson P. S100B overexpressing mutant mice exhibit prolonged behavioural and biochemical responses towards repeated intermittent binge treatments with MDMA. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 12: 201-15. PMID 18812013 DOI: 10.1017/S1461145708009437  1
2009 Qi H, Mailliet F, Spedding M, Rocher C, Zhang X, Delagrange P, McEwen B, Jay TM, Svenningsson P. Antidepressants reverse the attenuation of the neurotrophic MEK/MAPK cascade in frontal cortex by elevated platform stress; reversal of effects on LTP is associated with GluA1 phosphorylation. Neuropharmacology. 56: 37-46. PMID 18657555 DOI: 10.1016/j.neuropharm.2008.06.068  1
2008 Ohman E, Nilsson A, Madeira A, Sjögren B, Andrén PE, Svenningsson P. Use of surface plasmon resonance coupled with mass spectrometry reveals an interaction between the voltage-gated sodium channel type X alpha-subunit and caveolin-1. Journal of Proteome Research. 7: 5333-8. PMID 19367709 DOI: 10.1021/pr800498t  1
2008 Eriksson TM, Golkar A, Ekström JC, Svenningsson P, Ogren SO. 5-HT7 receptor stimulation by 8-OH-DPAT counteracts the impairing effect of 5-HT(1A) receptor stimulation on contextual learning in mice. European Journal of Pharmacology. 596: 107-10. PMID 18789922 DOI: 10.1016/j.ejphar.2008.08.026  1
2008 Bateup HS, Svenningsson P, Kuroiwa M, Gong S, Nishi A, Heintz N, Greengard P. Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs. Nature Neuroscience. 11: 932-9. PMID 18622401 DOI: 10.1038/nn.2153  1
2008 Sjögren B, Csöregh L, Svenningsson P. Cholesterol reduction attenuates 5-HT1A receptor-mediated signaling in human primary neuronal cultures. Naunyn-Schmiedeberg's Archives of Pharmacology. 378: 441-6. PMID 18607571 DOI: 10.1007/s00210-008-0323-6  1
2008 Mailliet F, Qi H, Rocher C, Spedding M, Svenningsson P, Jay TM. Protection of stress-induced impairment of hippocampal/prefrontal LTP through blockade of glucocorticoid receptors: implication of MEK signaling. Experimental Neurology. 211: 593-6. PMID 18436212 DOI: 10.1016/j.expneurol.2008.02.030  1
2008 Zhang X, Andren PE, Chergui K, Svenningsson P. Neurokinin B/NK3 receptors exert feedback inhibition on L-DOPA actions in the 6-OHDA lesion rat model of Parkinson's disease. Neuropharmacology. 54: 1143-52. PMID 18423776 DOI: 10.1016/j.neuropharm.2008.03.005  1
2008 Ogren SO, Eriksson TM, Elvander-Tottie E, D'Addario C, Ekström JC, Svenningsson P, Meister B, Kehr J, Stiedl O. The role of 5-HT(1A) receptors in learning and memory. Behavioural Brain Research. 195: 54-77. PMID 18394726 DOI: 10.1016/j.bbr.2008.02.023  1
2008 Eriksson TM, Madjid N, Elvander-Tottie E, Stiedl O, Svenningsson P, Ogren SO. Blockade of 5-HT 1B receptors facilitates contextual aversive learning in mice by disinhibition of cholinergic and glutamatergic neurotransmission. Neuropharmacology. 54: 1041-50. PMID 18394658 DOI: 10.1016/j.neuropharm.2008.02.007  1
2008 Zhang X, Andren PE, Greengard P, Svenningsson P. Evidence for a role of the 5-HT1B receptor and its adaptor protein, p11, in L-DOPA treatment of an animal model of Parkinsonism. Proceedings of the National Academy of Sciences of the United States of America. 105: 2163-8. PMID 18256188 DOI: 10.1073/pnas.0711839105  1
2008 Millan MJ, Svenningsson P, Ashby CR, Hill M, Egeland M, Dekeyne A, Brocco M, Di Cara B, Lejeune F, Thomasson N, Munoz C, Mocaër E, Crossman A, Cistarelli L, Girardon S, et al. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent. II. A neurochemical, electrophysiological and behavioral characterization in vivo. The Journal of Pharmacology and Experimental Therapeutics. 324: 600-11. PMID 18024787 DOI: 10.1124/jpet.107.132563  1
2008 Smith DG, Qi H, Svenningsson P, Wade M, Davis RJ, Gehlert DR, Nomikos GG. Behavioral and biochemical responses to d-amphetamine in MCH1 receptor knockout mice. Synapse (New York, N.Y.). 62: 128-36. PMID 18000809 DOI: 10.1002/syn.20473  1
2007 Svenningsson P, Bateup H, Qi H, Takamiya K, Huganir RL, Spedding M, Roth BL, McEwen BS, Greengard P. Involvement of AMPA receptor phosphorylation in antidepressant actions with special reference to tianeptine. The European Journal of Neuroscience. 26: 3509-17. PMID 18088278 DOI: 10.1111/j.1460-9568.2007.05952.x  1
2007 Sköld K, Svensson M, Norrman M, Sjögren B, Svenningsson P, Andrén PE. The significance of biochemical and molecular sample integrity in brain proteomics and peptidomics: stathmin 2-20 and peptides as sample quality indicators. Proteomics. 7: 4445-56. PMID 18072205 DOI: 10.1002/pmic.200700142  1
2007 Sjögren B, Svenningsson P. Caveolin-1 affects serotonin binding and cell surface levels of human 5-HT7(a) receptors. Febs Letters. 581: 5115-21. PMID 17936759 DOI: 10.1016/j.febslet.2007.09.059  1
2007 Nilsson A, Sköld K, Sjögren B, Svensson M, Pierson J, Zhang X, Caprioli RM, Buijs J, Persson B, Svenningsson P, Andrén PE. Increased striatal mRNA and protein levels of the immunophilin FKBP-12 in experimental Parkinson's disease and identification of FKBP-12-binding proteins. Journal of Proteome Research. 6: 3952-61. PMID 17877381 DOI: 10.1021/pr070189e  1
2007 Kindlundh-Högberg AM, Schiöth HB, Svenningsson P. Repeated intermittent MDMA binges reduce DAT density in mice and SERT density in rats in reward regions of the adolescent brain. Neurotoxicology. 28: 1158-69. PMID 17692920 DOI: 10.1016/j.neuro.2007.07.002  1
2007 Zhang X, Andren PE, Svenningsson P. Changes on 5-HT2 receptor mRNAs in striatum and subthalamic nucleus in Parkinson's disease model. Physiology & Behavior. 92: 29-33. PMID 17588622 DOI: 10.1016/j.physbeh.2007.05.033  1
2007 Kaplan A, Söderström M, Fenyö D, Nilsson A, Fälth M, Sköld K, Svensson M, Pettersen H, Lindqvist S, Svenningsson P, Andrén PE, Björkesten L. An automated method for scanning LC-MS data sets for significant peptides and proteins, including quantitative profiling and interactive confirmation. Journal of Proteome Research. 6: 2888-95. PMID 17559249 DOI: 10.1021/pr060676e  1
2007 Witkovsky P, Svenningsson P, Yan L, Bateup H, Silver R. Cellular localization and function of DARPP-32 in the rodent retina. The European Journal of Neuroscience. 25: 3233-42. PMID 17552992 DOI: 10.1111/j.1460-9568.2007.05571.x  0.44
2007 Svensson M, Sköld K, Nilsson A, Fälth M, Svenningsson P, Andrén PE. Neuropeptidomics: expanding proteomics downwards. Biochemical Society Transactions. 35: 588-93. PMID 17511658 DOI: 10.1042/BST0350588  1
2007 Svenningsson P, Tzavara ET, Qi H, Carruthers R, Witkin JM, Nomikos GG, Greengard P. Biochemical and behavioral evidence for antidepressant-like effects of 5-HT6 receptor stimulation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 4201-9. PMID 17428998 DOI: 10.1523/JNEUROSCI.3110-06.2007  1
2007 Sjögren B, Svenningsson P. Depletion of the lipid raft constituents, sphingomyelin and ganglioside, decreases serotonin binding at human 5-HT7(a) receptors in HeLa cells. Acta Physiologica (Oxford, England). 190: 47-53. PMID 17428232 DOI: 10.1111/j.1365-201X.2007.01687.x  1
2007 Agid Y, Buzsáki G, Diamond DM, Frackowiak R, Giedd J, Girault JA, Grace A, Lambert JJ, Manji H, Mayberg H, Popoli M, Prochiantz A, Richter-Levin G, Somogyi P, Spedding M, ... Svenningsson P, et al. How can drug discovery for psychiatric disorders be improved? Nature Reviews. Drug Discovery. 6: 189-201. PMID 17330070 DOI: 10.1038/nrd2217  1
2007 Svensson M, Sköld K, Nilsson A, Fälth M, Nydahl K, Svenningsson P, Andrén PE. Neuropeptidomics: MS applied to the discovery of novel peptides from the brain. Analytical Chemistry. 79: 15-6, 18-21. PMID 17262921 DOI: 10.1021/ac071856q  1
2007 Svenningsson P, Greengard P. p11 (S100A10)--an inducible adaptor protein that modulates neuronal functions. Current Opinion in Pharmacology. 7: 27-32. PMID 17085073 DOI: 10.1016/j.coph.2006.10.001  1
2007 Chergui K, Fredholm BB, Svenningsson P. Many ways to Rome - multiple approaches to novel drugs Current Opinion in Pharmacology. 7: 1-2. DOI: 10.1016/j.coph.2006.12.002  1
2007 Sköld K, Svensson M, Nilsson A, Fälth M, Svenningsson P, Andrén P. The Importance of Sample Handling in Neuropeptidomics Peptidomics: Methods and Applications. 177-189. DOI: 10.1002/9780470196502.ch9  1
2007 Sköld K, Fälth M, Svensson M, Nilsson A, Svenningsson P, Andrén PE. Strategies for Reliable and Improved Identification of Peptides Peptidomics: Methods and Applications. 139-152. DOI: 10.1002/9780470196502.ch7  1
2006 Sjögren B, Hamblin MW, Svenningsson P. Cholesterol depletion reduces serotonin binding and signaling via human 5-HT(7(a)) receptors. European Journal of Pharmacology. 552: 1-10. PMID 17064686 DOI: 10.1016/j.ejphar.2006.08.069  1
2006 Yan L, Bobula JM, Svenningsson P, Greengard P, Silver R. DARPP-32 involvement in the photic pathway of the circadian system. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 9434-8. PMID 16971527 DOI: 10.1523/JNEUROSCI.2538-06.2006  1
2006 Kindlundh-Högberg AM, Svenningsson P, Schiöth HB. Quantitative mapping shows that serotonin rather than dopamine receptor mRNA expressions are affected after repeated intermittent administration of MDMA in rat brain. Neuropharmacology. 51: 838-47. PMID 16820177 DOI: 10.1016/j.neuropharm.2006.05.026  1
2006 Zhang X, Andren PE, Svenningsson P. Repeated l-DOPA treatment increases c-fos and BDNF mRNAs in the subthalamic nucleus in the 6-OHDA rat model of Parkinson's disease. Brain Research. 1095: 207-10. PMID 16725125 DOI: 10.1016/j.brainres.2006.04.019  1
2006 Allen PB, Zachariou V, Svenningsson P, Lepore AC, Centonze D, Costa C, Rossi S, Bender G, Chen G, Feng J, Snyder GL, Bernardi G, Nestler EJ, Yan Z, Calabresi P, et al. Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity. Neuroscience. 140: 897-911. PMID 16600521 DOI: 10.1016/j.neuroscience.2006.02.067  1
2006 Zhang Y, Svenningsson P, Picetti R, Schlussman SD, Nairn AC, Ho A, Greengard P, Kreek MJ. Cocaine self-administration in mice is inversely related to phosphorylation at Thr34 (protein kinase A site) and Ser130 (kinase CK1 site) of DARPP-32. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 2645-51. PMID 16525043 DOI: 10.1523/JNEUROSCI.3923-05.2006  1
2006 Sköld K, Svensson M, Nilsson A, Zhang X, Nydahl K, Caprioli RM, Svenningsson P, Andrén PE. Decreased striatal levels of PEP-19 following MPTP lesion in the mouse. Journal of Proteome Research. 5: 262-9. PMID 16457591 DOI: 10.1021/pr050281f  1
2006 Svenningsson P, Chergui K, Rachleff I, Flajolet M, Zhang X, El Yacoubi M, Vaugeois JM, Nomikos GG, Greengard P. Alterations in 5-HT1B receptor function by p11 in depression-like states. Science (New York, N.Y.). 311: 77-80. PMID 16400147 DOI: 10.1126/science.1117571  1
2006 Zachariou V, Sgambato-Faure V, Sasaki T, Svenningsson P, Berton O, Fienberg AA, Nairn AC, Greengard P, Nestler EJ. Phosphorylation of DARPP-32 at Threonine-34 is required for cocaine action. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 555-62. PMID 16123776 DOI: 10.1038/sj.npp.1300832  1
2006 Zhang X, Svenningsson P. Parkinson's disease, the dopamine system and immediate early genes Immediate Early Genes in Sensory Processing, Cognitive Performance and Neurological Disorders. 261-290. DOI: 10.1007/978-0-387-33604-6_14  1
2006 Svenningsson P, Greengard P. A master regulator in the brain Scientist. 20: 40-47.  1
2005 Svenningsson P, Nairn AC, Greengard P. DARPP-32 mediates the actions of multiple drugs of abuse. The Aaps Journal. 7: E353-60. PMID 16353915 DOI: 10.1208/aapsj070235  1
2005 Andersson M, Usiello A, Borgkvist A, Pozzi L, Dominguez C, Fienberg AA, Svenningsson P, Fredholm BB, Borrelli E, Greengard P, Fisone G. Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 8432-8. PMID 16162925 DOI: 10.1523/JNEUROSCI.1289-05.2005  1
2005 Chergui K, Svenningsson P, Greengard P. Physiological role for casein kinase 1 in glutamatergic synaptic transmission. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 6601-9. PMID 16014721 DOI: 10.1523/JNEUROSCI.1082-05.2005  1
2005 Ryan XP, Alldritt J, Svenningsson P, Allen PB, Wu GY, Nairn AC, Greengard P. The Rho-specific GEF Lfc interacts with neurabin and spinophilin to regulate dendritic spine morphology. Neuron. 47: 85-100. PMID 15996550 DOI: 10.1016/j.neuron.2005.05.013  1
2005 Pierson J, Svenningsson P, Caprioli RM, Andren PE. Increased levels of ubiquitin in the 6-OHDA-lesioned striatum of rats. Journal of Proteome Research. 4: 223-6. PMID 15822896 DOI: 10.1021/pr049836h  1
2005 Fredholm BB, Chen JF, Cunha RA, Svenningsson P, Vaugeois JM. Adenosine and brain function. International Review of Neurobiology. 63: 191-270. PMID 15797469 DOI: 10.1016/S0074-7742(05)63007-3  1
2005 Valjent E, Pascoli V, Svenningsson P, Paul S, Enslen H, Corvol JC, Stipanovich A, Caboche J, Lombroso PJ, Nairn AC, Greengard P, Hervé D, Girault JA. Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proceedings of the National Academy of Sciences of the United States of America. 102: 491-6. PMID 15608059 DOI: 10.1073/pnas.0408305102  1
2004 Nairn AC, Svenningsson P, Nishi A, Fisone G, Girault JA, Greengard P. The role of DARPP-32 in the actions of drugs of abuse. Neuropharmacology. 47: 14-23. PMID 15464122 DOI: 10.1016/j.neuropharm.2004.05.010  1
2004 Lee SJ, Romeo RD, Svenningsson P, Campomanes CR, Allen PB, Greengard P, McEwen BS. Estradiol affects spinophilin protein differently in gonadectomized males and females. Neuroscience. 127: 983-8. PMID 15312910 DOI: 10.1016/j.neuroscience.2004.05.049  1
2004 Pierson J, Norris JL, Aerni HR, Svenningsson P, Caprioli RM, Andrén PE. Molecular profiling of experimental Parkinson's disease: direct analysis of peptides and proteins on brain tissue sections by MALDI mass spectrometry. Journal of Proteome Research. 3: 289-95. PMID 15113106 DOI: 10.1021/pr0499747  1
2004 Allen PB, Greenfield AT, Svenningsson P, Haspeslagh DC, Greengard P. Phactrs 1-4: A family of protein phosphatase 1 and actin regulatory proteins. Proceedings of the National Academy of Sciences of the United States of America. 101: 7187-92. PMID 15107502 DOI: 10.1073/pnas.0401673101  1
2004 Chergui K, Svenningsson P, Greengard P. Cyclin-dependent kinase 5 regulates dopaminergic and glutamatergic transmission in the striatum. Proceedings of the National Academy of Sciences of the United States of America. 101: 2191-6. PMID 14769920 DOI: 10.1073/pnas.0308652100  1
2004 Svenningsson P, Nishi A, Fisone G, Girault JA, Nairn AC, Greengard P. DARPP-32: an integrator of neurotransmission. Annual Review of Pharmacology and Toxicology. 44: 269-96. PMID 14744247 DOI: 10.1146/annurev.pharmtox.44.101802.121415  1
2004 Nilsson LJ, Johansson B, Åstrand K, Ericsson K, Svenningsson P, Börjesson P, Neij L. Seeing the wood for the trees: 25 years of renewable energy policy in Sweden Energy For Sustainable Development. 8: 67-81. DOI: 10.1016/S0973-0826(08)60392-0  0.6
2003 Fukui R, Svenningsson P, Matsuishi T, Higashi H, Nairn AC, Greengard P, Nishi A. Effect of methylphenidate on dopamine/DARPP signalling in adult, but not young, mice. Journal of Neurochemistry. 87: 1391-401. PMID 14713295  1
2003 Svenningsson P, Fredholm BB. Exciting news about A2A receptors. Neurology. 61: S10-1. PMID 14663002  1
2003 Fredholm BB, Svenningsson P. Adenosine-dopamine interactions: development of a concept and some comments on therapeutic possibilities. Neurology. 61: S5-9. PMID 14663001  1
2003 Svenningsson P, Tzavara ET, Carruthers R, Rachleff I, Wattler S, Nehls M, McKinzie DL, Fienberg AA, Nomikos GG, Greengard P. Diverse psychotomimetics act through a common signaling pathway. Science (New York, N.Y.). 302: 1412-5. PMID 14631045 DOI: 10.1126/science.1089681  1
2003 Svensson M, Sköld K, Svenningsson P, Andren PE. Peptidomics-based discovery of novel neuropeptides. Journal of Proteome Research. 2: 213-9. PMID 12716136 DOI: 10.1021/pr020010u  1
2003 Fredholm BB, Cunha RA, Svenningsson P. Pharmacology of adenosine A2A receptors and therapeutic applications. Current Topics in Medicinal Chemistry. 3: 413-26. PMID 12570759  1
2003 Andren PE, Svensson M, Sköld K, Svenningsson P. Chapter 8 Peptidomics-based discovery of endogenous neuropeptides in the brain Journal of Chromatography Library. 68: 155-167. DOI: 10.1016/S0301-4770(03)80010-6  1
2002 Svenningsson P, Arts J, Gunne L, Andren PE. Acute and repeated treatment with L-DOPA increase c-jun expression in the 6-hydroxydopamine-lesioned forebrain of rats and common marmosets. Brain Research. 955: 8-15. PMID 12419516 DOI: 10.1016/S0006-8993(02)03289-4  1
2002 Klintenberg R, Svenningsson P, Gunne L, Andrén PE. Naloxone reduces levodopa-induced dyskinesias and apomorphine-induced rotations in primate models of parkinsonism. Journal of Neural Transmission (Vienna, Austria : 1996). 109: 1295-307. PMID 12373562 DOI: 10.1007/s00702-002-0715-6  1
2002 Lindskog M, Svenningsson P, Pozzi L, Kim Y, Fienberg AA, Bibb JA, Fredholm BB, Nairn AC, Greengard P, Fisone G. Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine. Nature. 418: 774-8. PMID 12181566 DOI: 10.1038/nature00817  1
2002 Svenningsson P, Tzavara ET, Liu F, Fienberg AA, Nomikos GG, Greengard P. DARPP-32 mediates serotonergic neurotransmission in the forebrain. Proceedings of the National Academy of Sciences of the United States of America. 99: 3188-93. PMID 11880652 DOI: 10.1073/pnas.052712699  1
2002 Svenningsson P, Tzavara ET, Witkin JM, Fienberg AA, Nomikos GG, Greengard P. Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac). Proceedings of the National Academy of Sciences of the United States of America. 99: 3182-7. PMID 11880651 DOI: 10.1073/pnas.052712799  1
2002 Svenningsson P, Le Moine C. Dopamine D1/5 receptor stimulation induces c-fos expression in the subthalamic nucleus: possible involvement of local D5 receptors. The European Journal of Neuroscience. 15: 133-42. PMID 11860513 DOI: 10.1046/j.0953-816x.2001.01840.x  1
2001 Bibb JA, Chen J, Taylor JR, Svenningsson P, Nishi A, Snyder GL, Yan Z, Sagawa ZK, Ouimet CC, Nairn AC, Nestler EJ, Greengard P. Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature. 410: 376-80. PMID 11268215 DOI: 10.1038/35066591  1
2001 Fredholm BB, Arslan G, Halldner L, Kull B, Schulte G, Ådén U, Svenningsson P. Adenosine receptor signaling in vitro and in vivo Drug Development Research. 52: 274-282. DOI: 10.1002/ddr.1124  1
2000 Calabresi P, Gubellini P, Centonze D, Picconi B, Bernardi G, Chergui K, Svenningsson P, Fienberg AA, Greengard P. Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 8443-51. PMID 11069952  1
2000 Svenningsson P, Gunne L, Andren PE. L-DOPA produces strong induction of c-fos messenger RNA in dopamine-denervated cortical and striatal areas of the common marmoset. Neuroscience. 99: 457-68. PMID 11029538 DOI: 10.1016/S0306-4522(00)00213-X  1
2000 Kull B, Svenningsson P, Fredholm BB. Adenosine A(2A) receptors are colocalized with and activate g(olf) in rat striatum. Molecular Pharmacology. 58: 771-7. PMID 10999947  1
2000 Kull B, Svenningsson P, Hall H, Fredholm BB. GTP differentially affects antagonist radioligand binding to adenosine A(1) and A(2A) receptors in human brain. Neuropharmacology. 39: 2374-80. PMID 10974321 DOI: 10.1016/S0028-3908(00)00081-2  1
2000 Svenningsson P, Fredholm BB, Bloch B, Le Moine C. Co-stimulation of D(1)/D(5) and D(2) dopamine receptors leads to an increase in c-fos messenger RNA in cholinergic interneurons and a redistribution of c-fos messenger RNA in striatal projection neurons. Neuroscience. 98: 749-57. PMID 10891618 DOI: 10.1016/S0306-4522(00)00155-X  1
2000 Svenningsson P, Fienberg AA, Allen PB, Moine CL, Lindskog M, Fisone G, Greengard P, Fredholm BB. Dopamine D(1) receptor-induced gene transcription is modulated by DARPP-32. Journal of Neurochemistry. 75: 248-57. PMID 10854268 DOI: 10.1046/j.1471-4159.2000.0750248.x  1
2000 Bibb JA, Yan Z, Svenningsson P, Snyder GL, Pieribone VA, Horiuchi A, Nairn AC, Messer A, Greengard P. Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice. Proceedings of the National Academy of Sciences of the United States of America. 97: 6809-14. PMID 10829080 DOI: 10.1073/pnas.120166397  1
2000 Svenningsson P, Lindskog M, Ledent C, Parmentier M, Greengard P, Fredholm BB, Fisone G. Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proceedings of the National Academy of Sciences of the United States of America. 97: 1856-60. PMID 10677546 DOI: 10.1073/pnas.97.4.1856  1
1999 Kull B, Ferré S, Arslan G, Svenningsson P, Fuxe K, Owman C, Fredholm BB. Reciprocal interactions between adenosine A2A and dopamine D2 receptors in Chinese hamster ovary cells co-transfected with the two receptors. Biochemical Pharmacology. 58: 1035-45. PMID 10509756 DOI: 10.1016/S0006-2952(99)00184-7  1
1999 Svenningsson P, Le Moine C, Fisone G, Fredholm BB. Distribution, biochemistry and function of striatal adenosine A2A receptors. Progress in Neurobiology. 59: 355-96. PMID 10501634 DOI: 10.1016/S0301-0082(99)00011-8  1
1999 Lindskog M, Svenningsson P, Fredholm B, Greengard P, Fisone G. Mu- and delta-opioid receptor agonists inhibit DARPP-32 phosphorylation in distinct populations of striatal projection neurons. The European Journal of Neuroscience. 11: 2182-6. PMID 10336688 DOI: 10.1046/j.1460-9568.1999.00597.x  1
1999 Lindskog M, Svenningsson P, Fredholm BB, Greengard P, Fisone G. Activation of dopamine D2 receptors decreases DARPP-32 phosphorylation in striatonigral and striatopallidal projection neurons via different mechanisms. Neuroscience. 88: 1005-8. PMID 10336115 DOI: 10.1016/S0306-4522(98)00411-4  1
1999 Svenningsson P, Nomikos GG, Fredholm BB. The stimulatory action and the development of tolerance to caffeine is associated with alterations in gene expression in specific brain regions. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 4011-22. PMID 10234030  1
1999 Svenningsson P, Fourreau L, Bloch B, Fredholm BB, Gonon F, Le Moine C. Opposite tonic modulation of dopamine and adenosine on c-fos gene expression in striatopallidal neurons. Neuroscience. 89: 827-37. PMID 10199616 DOI: 10.1016/S0306-4522(98)00403-5  1
1998 Svenningsson P, Le Moine C, Aubert I, Burbaud P, Fredholm BB, Bloch B. Cellular distribution of adenosine A2A receptor mRNA in the primate striatum. The Journal of Comparative Neurology. 399: 229-40. PMID 9721905 DOI: 10.1002/(SICI)1096-9861(19980921)399:2<229::AID-CNE6>3.0.CO;2-2  1
1998 Svenningsson P, NergÃ¥rdh R, Fredholm BB. Regional differences in the ability of caffeine to affect haloperidol-induced striatal c-fos mRNA expression in the rat. Neuropharmacology. 37: 331-7. PMID 9681931 DOI: 10.1016/S0028-3908(98)00045-8  1
1998 Fredholm BB, Svenningsson P. Striatal adenosine A2A receptors--where are they? What do they do? Trends in Pharmacological Sciences. 19: 46-8. PMID 9550940 DOI: 10.1016/S0165-6147(97)01160-7  1
1998 Svenningsson P, Lindskog M, Rognoni F, Fredholm BB, Greengard P, Fisone G. Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons. Neuroscience. 84: 223-8. PMID 9522376 DOI: 10.1016/S0306-4522(97)00510-1  1
1998 Fredholm BB, Arslan G, Kuli B, Svenningsson P. Locating the neuronal targets for caffeine Drug Development Research. 45: 324-328.  1
1997 Chergui K, Svenningsson P, Nomikos GG, Gonon F, Fredholm BB, Svennson TH. Increased expression of NGFI-A mRNA in the rat striatum following burst stimulation of the medial forebrain bundle. The European Journal of Neuroscience. 9: 2370-82. PMID 9464931  1
1997 Svenningsson P, Georgieva J, Kontny E, Heilig M, Fredholm BB. Involvement of a c-fos-dependent mechanism in caffeine-induced expression of the preprotachykinin A and neurotensin/neuromedin N genes in rat striatum. The European Journal of Neuroscience. 9: 2135-41. PMID 9421173 DOI: 10.1111/j.1460-9568.1997.tb01380.x  1
1997 Svenningsson P, Hall H, Sedvall G, Fredholm BB. Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study. Synapse (New York, N.Y.). 27: 322-35. PMID 9372555 DOI: 10.1002/(SICI)1098-2396(199712)27:4<322::AID-SYN6>3.0.CO;2-E  1
1997 Svenningsson P, Fredholm BB. Caffeine mimics the effect of a dopamine D2/3 receptor agonist on the expression of immediate early genes in globus pallidus. Neuropharmacology. 36: 1309-17. PMID 9364486 DOI: 10.1016/S0028-3908(97)00091-9  1
1997 Le Moine C, Svenningsson P, Fredholm BB, Bloch B. Dopamine-adenosine interactions in the striatum and the globus pallidus: inhibition of striatopallidal neurons through either D2 or A2A receptors enhances D1 receptor-mediated effects on c-fos expression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 8038-48. PMID 9315922  1
1997 Svenningsson P, Le Moine C, Kull B, Sunahara R, Bloch B, Fredholm BB. Cellular expression of adenosine A2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas. Neuroscience. 80: 1171-85. PMID 9284069 DOI: 10.1016/S0306-4522(97)00180-2  1
1997 Svenningsson P, Nomikos GG, Ongini E, Fredholm BB. Antagonism of adenosine A2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens. Neuroscience. 79: 753-64. PMID 9219939 DOI: 10.1016/S0306-4522(97)00046-8  1
1997 Kontny E, Ciruela F, Svenningsson P, Ibáñez CF, Fredholm BB. On the role of the low-affinity neurotrophin receptor p75LNTR in nerve growth factor induction of differentiation and AP 1 binding activity in PC12 cells. Journal of Molecular Neuroscience : Mn. 8: 29-44. PMID 9061613 DOI: 10.1007/BF02736861  1
1997 Svenningsson P, Fredholm BB. Glucocorticoids regulate the expression of adenosine A1 but not A(2A) receptors in rat brain. The Journal of Pharmacology and Experimental Therapeutics. 280: 1094-101. PMID 9023328  1
1996 Ferre S, O'Connor WT, Svenningsson P, Bjorklund L, Lindberg J, Tinner B, Stromberg I, Goldstein M, Ogren SO, Ungerstedt U, Fredholm BB, Fuxe K. Dopamine D1 receptor-mediated facilitation of GABAergic neurotransmission in the rat strioentopenduncular pathway and its modulation by adenosine A1 receptor-mediated mechanisms. The European Journal of Neuroscience. 8: 1545-53. PMID 8758962  1
1996 Svenningsson P, Johansson B, Fredholm BB. Caffeine-induced expression of c-fos mRNA and NGFI-A mRNA in caudate putamen and in nucleus accumbens are differentially affected by the N-methyl-D-aspartate receptor antagonist MK-801. Brain Research. Molecular Brain Research. 35: 183-9. PMID 8717354  1
1996 Fernandez M, Svenningsson P, Fredholm BB. Adaptive changes in adenosine receptors following long-term treatment with the adenosine receptor agonist R-phenylisopropyl adenosine. Life Sciences. 58: 769-76. PMID 8632724 DOI: 10.1016/0024-3205(95)02355-0  1
1996 Ongini E, Dionisotti S, Morelli M, Ferrere S, Svenningsson P, Fuxe K, Fredholm BB. Neuropharmacology of the adenosine A(2A) receptors Drug Development Research. 39: 450-460.  1
1996 Fredholm BB, Arslan G, Kull B, Kontny E, Svenningsson P. Adenosine (P1) receptor signalling Drug Development Research. 39: 262-268.  1
1995 Svenningsson P, Ström A, Johansson B, Fredholm BB. Increased expression of c-jun, junB, AP-1, and preproenkephalin mRNA in rat striatum following a single injection of caffeine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 3583-93. PMID 7751931  1
1995 Svenningsson P, Johansson B, Fredholm BB. Effect of different xanthines and phosphodiesterase inhibitors on c-fos expression in rat striatum. Acta Physiologica Scandinavica. 154: 17-24. PMID 7572198 DOI: 10.1111/j.1748-1716.1995.tb09881.x  1
1995 Svenningsson P, Nomikos GG, Fredholm BB. Biphasic changes in locomotor behavior and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 7612-24. PMID 7472512  1
1992 Johansson B, Svenningsson P, Adén U, Lindström K, Fredholm BB. Evidence that the increase in striatal c-fos following acute high-dose caffeine is not due to direct interaction with striatal adenosine receptors. Acta Physiologica Scandinavica. 146: 539-41. PMID 1492572 DOI: 10.1111/j.1748-1716.1992.tb09461.x  1
Show low-probability matches.